Urinary eosinophil protein X in children with atopic dermatitis: relation to atopy and disease activity

被引:17
作者
Oymar, K
Bjerknes, R
机构
[1] Rogland Cty Hosp, Dept Pediat, N-4003 Stavanger, Norway
[2] Univ Bergen, Haukeland Hosp, Dept Pediat, N-5021 Bergen, Norway
关键词
atopic dermatitis; atopy; EPX;
D O I
10.1034/j.1398-9995.2000.00682.x
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Background: Parameters of eosinophil inflammation have been suggested as markers of disease activity in atopic dermatitis (AD), but the value of urinary eosinophil protein X (U-EPX) in children with AD, as well as the influence of allergic sensitization, is not known. Methods: We measured U-EPX in 59 atopic and 29 nonatopic children with mild (n = 32), moderate (n = 34), and severe (n = 22) AD, as well as in 64 controls. Results: U-EPX was increased in children with AD (110; 67-164 mu g/mmol creatinine, median; quartiles) compared to controls (62; 41-95, P<0.001). Children with mild (97; 63-164, P<0.01), moderate (108; 67-157, P<0.01), and severe disease (152; 99-202, P<0.001) had levels of U-EPX higher than controls. U-EPX was significantly higher in children with severe AD than in mild and moderate disease (P<0.05 for both). Children with AD and a positive skin prick test (120; 81-176) had higher levels of U-EPX than children with a negative skin prick test (87; 56-155, P<0.05). Conclusions: U-EPX is significantly increased in children with AD and may reflect disease activity. U-EPX may also reflect differences in eosinophil activation between those sensitized and those not sensitized to common allergens.
引用
收藏
页码:964 / 968
页数:5
相关论文
共 25 条
[1]  
[Anonymous], ACTA DERM VENERE S92, DOI [10.2340/00015555924447, DOI 10.2340/00015555924447]
[2]   EOSINOPHIL INFLAMMATION IN ASTHMA [J].
BOUSQUET, J ;
CHANEZ, P ;
VIGNOLA, AM ;
LACOSTE, JY ;
MICHEL, FB .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1994, 150 (05) :S33-S38
[3]   Urinary eosinophil-derived neurotoxin/protein X: A simple method for assessing eosinophil degranulation in vivo [J].
Cottin, V ;
Deviller, P ;
Tardy, F ;
Cordier, JF .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1998, 101 (01) :116-123
[4]   SERUM EOSINOPHIL CATIONIC PROTEIN (ECP) IS A SENSITIVE MEASURE FOR DISEASE-ACTIVITY IN ATOPIC-DERMATITIS [J].
CZECH, W ;
KRUTMANN, J ;
SCHOPF, E ;
KAPP, A .
BRITISH JOURNAL OF DERMATOLOGY, 1992, 126 (04) :351-355
[5]   IL-5 as a strong secretagogue for human eosinophils [J].
Fujisawa, T ;
Terada, A ;
Atsuta, J ;
Iguchi, K ;
Kamiya, H ;
Sakurai, M .
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 1997, 114 :81-83
[6]  
Furue M, 1999, BRIT J DERMATOL, V140, P67
[7]   Monitoring of disease activity by measurement of inflammatory markers in atopic dermatitis in childhood [J].
Halmerbauer, G ;
Frischer, T ;
Koller, DY .
ALLERGY, 1997, 52 (07) :765-769
[8]   CORRELATION OF EOSINOPHILS, EOSINOPHIL CATIONIC PROTEIN AND SOLUBLE INTERLEUKIN-2 RECEPTOR WITH THE CLINICAL ACTIVITY OF ATOPIC-DERMATITIS [J].
KAGI, MK ;
JOLLERJEMELKA, H ;
WUTHRICH, B .
DERMATOLOGY, 1992, 185 (02) :88-92
[9]   THE ROLE OF EOSINOPHILS IN THE PATHOGENESIS OF ATOPIC-DERMATITIS - EOSINOPHIL GRANULE PROTEINS AS MARKERS OF DISEASE-ACTIVITY [J].
KAPP, A .
ALLERGY, 1993, 48 (01) :1-5
[10]   EOSINOPHILS IN ATOPIC-DERMATITIS [J].
LEIFERMAN, KM .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1994, 94 (06) :1310-1317